Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2012. The document serves as a notice of the Company's Annual General Meeting (AGM) scheduled for May 3, 2012, at the Queen Elizabeth II Conference Centre in London.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is administrative in nature and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It solely announces the date, time, and location of the upcoming AGM and directs investors to the company website and the UK Listing Authority for the full notice.
Key Facts for Investors to Verify
- AGM Date: Thursday, May 3, 2012.
- AGM Time: 2:30 pm (UK time).
- AGM Location: Queen Elizabeth II Conference Centre, Westminster, London.
- Full Notice Availability: Available on www.gsk.com and via the UK Listing Authority National Storage Mechanism.